AC-3933

· Sumitomo Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AC-3933, covering 2013-07-02 to 2013-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease [Phase 2]